EnvarsusXR (Veloxis Pharmaceuticals, Inc)
Welcome to the PulseAid listing for the Envarsus drug offered from Veloxis Pharmaceuticals, Inc. This Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Veloxis Pharmaceuticals, Inc |
| NON-PROPRIETARY NAME: | Tacrolimus |
| SUBSTANCE NAME: | TACROLIMUS |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, EXTENDED RELEASE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-09-01 |
| END MARKETING DATE: | 0000-00-00 |
Envarsus XR HUMAN PRESCRIPTION DRUG Details:
| Item Description | Envarsus XR from Veloxis Pharmaceuticals, Inc |
| LABELER NAME: | Veloxis Pharmaceuticals, Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1(mg/1) |
| START MARKETING DATE: | 2015-09-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 68992-3010_f99bc24f-1f15-4921-8fde-741d76360313 |
| PRODUCT NDC: | 68992-3010 |
| APPLICATION NUMBER: | NDA206406 |
Other TACROLIMUS Pharmaceutical Manufacturers / Labelers:
